Valerjans Kauss - Head of Laboratory - Latvian Institute of Organic Synthesis | LinkedIn
Valerjans Kauss - Head of Laboratory - Latvian Institute of Organic Synthesis | LinkedIn
Пасхальный турнир в г. Бауске по шашкам 64 по 15 минут и блитц по 9 туров 30.03.18 | dambrete
LU fotoarhīvs. Zinātnes kafejnīca - "Kā noveco smadzenes"
Foto | LETA
Methylprenyl and Prenyl Protection for Sulfonamides
President
Meik SLADEK | Merz, Frankfurt am Main | R&D
Valerjans KAUSS | Dr. Chem. | Latvian Institute of Organic Synthesis, Riga | Latvian IOS | Department of Medicinal Chemistry
Giovanni Serpelloni | 2° International Scientific School | Novel Psychoactive Substances: focus on Novel Synthetic Opioids
Valerjans KAUSS
Sumina Latvijas gudrākos prātus | LA.LV
Stereoselektīvas sintēzes pētījumi eksociklisko C=C dubultsaiti saturošu savienojumu klasēs - Latvijas Organiskās sintēzes institūts
Full article: Synthesis of 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides and their evaluation as ligands for NMDA receptor glycine binding site
LU fotoarhīvs. Zinātnes kafejnīca - "Kā noveco smadzenes"
RTU Doktorantūras absolventu gadagrāmata 2015 by Santa Rendore - issuu
Team - Justso
RTU Doktorantūras absolventu gadagrāmata 2015 by Santa Rendore - issuu
Foto | LETA
EIROPAS SOCIĀLĀ FONDA PROJEKTS
Analysis, knowledge dissemination, justice implementation and special testing of novel synthetic opioids - Latvijas Organiskās sintēzes institūts
US6034134A - 1-Amino-alkylcyclohexane NMDA receptor antagonists - Google Patents
Team - Justso
Intrinsic Activity – ©Austrian Pharmacological Society
